Genentech ยท 5 hours ago
Data Engineer
New York, NY
Full-time
Onsite
Mid Level
$128K/yr - $238K/yr
3+ years expGenentech is at the forefront of a revolutionary transformation in drug discovery powered by AI and machine learning. They are seeking an exceptional Data Engineer to build and maintain their next-generation Therapeutic Molecule Registration platform, which will manage and integrate molecular data across their global research organization.
BiotechnologyLife ScienceManufacturing
Responsibilities
Implement features of our TMR platform
Write clean, well-tested code following team standards
Build and maintain data pipelines
Facilitate data migration to TMR and production deployment
Participate in code reviews and technical discussions
Contribute to documentation and testing efforts
Collaborate with team members on technical solutions
Qualification
Required
3+ years of data engineering experience
Strong experience with Postgres SQL and Oracle
Skilled with at least one modern data toolkit (Glue, dbt, Databricks,...)
Cloud platform exposure (preferably AWS)
Python programming skills
Strong testing practices
Bachelor's degree in Computer Science or related field (or equivalent experience)
Preferred
Experience with data modelling & schema design
Involvement in a database migration
Familiarity with scientific software
Interest in chemical/biological data systems
Experience with AWS services
Benefits
Relocation benefits are available for this job posting
A discretionary annual bonus may be available based on individual and Company performance.
Company
Genentech
Genentech is a biotechnology research company that specializes in genetic testing and personalized medicines.
10001+ employees
H1B Sponsorship
Genentech has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (167)
2024 (148)
2023 (150)
2022 (178)
2021 (121)
2020 (158)
Funding
Current Stage
Public CompanyTotal Funding
unknown2009-03-26Acquired
1999-07-20IPO
1976-01-01Series Unknown
Leadership Team
Ashley Magargee
Chief Executive Officer
Michael Laird
Vice President, Global MSAT Drug Substance Biologics Technology and Commercial Products Support
Recent News
2026-01-07
Company data provided by crunchbase